SEFANID Suspension

Cefadroxil Monohydrate USP

Composition : Cefadroxil USP 125mg/5ml Suspension

Indication : Cefadroxil is indicated for the treatment of patients with urinary tract infection caused by Escherichia coli, Proteus mirabilis and Klebsiella species. Skin and skin structure infections caused by staphylococci, Pharyngitis and Tonsillitis caused by streptococcus pyogenes (Group A betahemolytic streptococci).

Dosage and administration : Administered orally and with food. Adults : Urinary Tract Infections : The usual dosage is 1gm or 2gm per day in single or divided doses. Skin and Skin Structure Infections : The usual dosage is 1gm per day in single or divided doses. Pharyngitis and Tonsillitis : The usual dosage is 1gm per day in single or divided doses. For urinary tract infections, the recommended daily dosage for children is 30mg/kg/day in divided doses every 12 hours.

Use in pregnancy and lactation : Cefadroxil has been assigned to pregnancy category B by the FDA.

Packing : Sefanid Suspension : 100ml Suspension.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2022 Designed and Developed by ATI Limited.